Reducing the Risk for HIV, Hepatitis C Among Injection Drug Users in New York
April 24, 2014
This article was reported by Infectious Disease Special Edition.
Infectious Disease Special Edition reported on a study showing that education and counseling services can control risky behaviors such as needle sharing in injection drug users (IDUs) and thus prevent HIV and hepatitis C virus (HCV) transmission in this high-risk community. Researchers at New York University's Center for Drug Use and HIV Research evaluated the efficacy of their Staying Safe Intervention, which was based on findings of a previous study in which they observed behaviors of IDUs.
The researchers enrolled 68 IDUs in a five-session Staying Safe education program. The program included safe injecting strategies, HIV and HCV risk in injection drug use, and ways of managing the risks. Of the 68 IDUs, 46 percent attended all sessions and 87 percent attended at least one session.View Full Article
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)